Home    Back

Tavt-18 (sirolimus)    (DrugBank: Sirolimus)

1 disease
IDDisease name (Link within this page)Number of trials
158Tuberous sclerosis1

158. Tuberous sclerosis    [ 100 clinical trials,   62 drugs,   (DrugBank: 16 drugs),   35 drug target genes,   115 drug target pathways]
Searched query = "Tuberous sclerosis", "Tuberous sclerosis complex"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 100 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04595513
(ClinicalTrials.gov)		September 8, 20206/10/2020Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC InfantsStopping TSC Onset and Progression 2: Epilepsy Prevention in TSC InfantsTuberous Sclerosis Complex;EpilepsyDrug: TAVT-18 (sirolimus);Drug: PlaceboChildren's Hospital Medical Center, CincinnatiNULLRecruitingN/A6 MonthsAll65Phase 1;Phase 2United States